- Home
- TNGX vs ATAT Comparison
TNGX vs ATAT Comparison
Compare TNGX & ATAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNGX | ATAT |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | China |
| Employees | 137 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.3B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TNGX | ATAT |
|---|---|---|
| Price | $24.77 | $35.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $21.78 | ★ $49.00 |
| AVG Volume (30 Days) | ★ 2.0M | 947.6K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 2.06% |
| EPS Growth | ★ 26.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $62,384,000.00 | N/A |
| Revenue This Year | N/A | $25.48 |
| Revenue Next Year | N/A | $18.11 |
| P/E Ratio | ★ N/A | $26.11 |
| Revenue Growth | ★ 48.29 | N/A |
| 52 Week Low | $6.25 | $30.78 |
| 52 Week High | $34.39 | $43.17 |
Technical Indicators
Market Signals| Indicator | TNGX | ATAT |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 53.45 |
| Support Level | $25.33 | $34.70 |
| Resistance Level | $25.76 | $35.88 |
| Average True Range (ATR) | 1.34 | 1.04 |
| MACD | -0.14 | -0.04 |
| Stochastic Oscillator | 35.47 | 48.27 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About ATAT Atour Lifestyle Holdings Limited
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.